Skip to main content

Springer Timothy A's Form 4 filing

Cartesian Therapeutics, Inc. (RNAC) · filed Apr 13, 2022

Accession no.
0001453687-22-000057
Filed
Apr 13, 2022
Trade date
Apr 11, 2022
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 1 non-derivative transaction and 1 derivative transaction. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Springer Timothy ACIK 0001055624Director, 10% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Apr 11, 2022Common StockPPurchaseAcquired+6,681,600–F1–29,868,490Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Apr 11, 2022Common StockAGrant or awardAcquired+5,011,200–F1–5,011,200Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Each share of common stock and accompanying warrant to purchase 0.75 shares of common stock was purchased at a combined ofering price of $1.41. The shares of common stock and accompanying warrants were acquired by the reporting person as units, but were issued separately and were immediately separable upon issuance.

Referenced by the price of 1 transaction in Table I and 1 transaction in Table II.

Read the full filing on SEC EDGAR (opens in a new tab)